1,5-benzothiazepine derivatives and their pharmaceutical use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602393B, A61K 3155, C07D28110

Patent

active

045901880

ABSTRACT:
Novel 1,5-benzothiazepine derivatives of the formula: ##STR1## wherein R.sup.1 is lower alkyl or lower alkoxy, R.sup.2 is hydrogen atom or lower alkanoyl, each one of R.sup.3 and R.sup.4 is lower alkyl, Ring A is a substituted benzene ring of the formula: ##STR2## R.sup.a is lower alkyl, lower alkoxy, lower alkylthio or benzyloxy, each one of R.sup.b and R.sup.c is lower alkyl, lower alkoxy or halogen atom, and either one of R.sup.d and R.sup.e is fluorine atom and the other one is hydrogen atom, or a pharmaceutically acceptable acid addition salt thereof are disclosed. Said derivative (I) and its salt are useful as a hypotensive agent and/or a cerebral or coronary vasodilator.

REFERENCES:
patent: 3075967 (1963-01-01), Krapcho
patent: 3309361 (1967-03-01), Krapcho et al.
patent: 3341516 (1967-09-01), Krapcho
patent: 3562257 (1971-02-01), Kugita et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,5-benzothiazepine derivatives and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,5-benzothiazepine derivatives and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,5-benzothiazepine derivatives and their pharmaceutical use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2108966

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.